With people of minority background and those with obesity and diabetes most at risk for severe cases of COVID-19, the National Institute of Diabetes and Digestive and Kidney Diseases is leading in the research behind why that is. Director Dr. Griffin Rodgers, who contributed to the first effective therapy for sickle cell anemia, updates HealthCast on the institute’s work to lessen the effects of COVID-19 on its research community, as well as other top research and data initiatives at the institution.
HealthCast
Season 2
Episode 17
21m listen
How One NIH Institute is Combating COVID-19 and Health Disparities
Share
NIDDK Director Dr. Griffin Rodgers talks COVID-19, disparities in health, and top priorities at the institute.
-
Dr. Griffin Rodgers Director NIDDK
Related Content
-
Misunderstood ATOs Are Costing Agencies Time, Money
Institutional confusion about ATOs is creating avoidable delays, while modern DevSecOps approaches offer a faster path to software delivery.
9m watch -
VA Pilot Shows Value of AI-Powered VR Training
A VA proof-of-concept pilot is demonstrating how AI-enabled virtual reality training boosts knowledge scores and lowers training costs.
3m read -
AI Powers Smithsonian’s Digital Transformation for America250
The Smithsonian is applying AI to research, digital collections and visitor experiences as it prepares for America250.
12m listen -
VA Deploys EHR System to Four More Medical Centers
More than 107,000 veterans and 7,200 clinicians are impacted by VA's latest electronic health record deployment across Ohio and Kentucky.
2m read
